Healthcare >> CEO Interviews >> December 14, 1998
DR. FRANK BALDINO is President, CEO and founder of Cephalon, Inc., an
international biopharmaceutical company focused on the development of
novel compounds to treat neurological diseases and cancer. Dr. Baldino's
scientific expertise and vision has led Cephalon to become one of the
industry's leading biopharmaceutical organizations. During his career,
Dr. Baldino has received numerous honors and awards for his outstanding
achievements in neuroscience and business, including the Entrepreneur of
the Year Awards from both the Delaware Valley Venture Capital
Association (1989) and from Ernst & Young (1991), and the Eastern
Technology Council of Greater Philadelphia's Enterprise Award for
Outstanding CEO Under 40 (1993) and CEO of the Year (1996). Dr. Baldino
has more than 16 years' scientific experience in neurobiology, molecular
biology and electrophysiology, and has authored more than 100
publications in peer-reviewed journals such as Nature, Journal of
Neuroscience Research and Brain Research. He received his Ph.D. from
Temple University in 1979 and held post-doctorate positions at the
University of Pennsylvania and UMDNJ-Rutgers Medical School. He also
holds adjunct academic appointments at Temple University and Allegheny
University Hospital in Philadelphia. From 1981-1987, Dr. Baldino served
as senior research biologist in the medical products department at E.I.
DuPont de Nemours & Company, where he was responsible for developing
research strategies for identifying novel neuropharmaceutical agents.
Dr. Baldino currently serves on the boards of Integrated Systems
Consulting Group, Inc., ViroPharma, Inc., Pharmacopeia, Inc. Adolor
Corporation, Biotechnology Industry Organization, and The Jackson
Laboratory. He serves on the advisory boards of the Benjamin Franklin
Barrow Awards, National Venture Capital Association, American
Entrepreneurs for Economic Growth, Eastern Technology Council of Greater
Philadelphia and Technology Leaders LP. Dr. Baldino is also a member of
the visiting committees for the University of Pennsylvania and
Muhlenberg College. Profile
your history, your activities?
Dr. Baldino: Cephalon is a fully integrated specialty biopharmaceutical
company that
